Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Revolutionising access to biology with transformational acquisition by Nuclera

13 mai 2021

par Ross McNaughton et Adrian Toutoungi

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 février 2021
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session

6 janvier 2021
Quick read

par Adrian Toutoungi

Cliquer ici pour en savoir plus
Pipets
Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23 novembre 2020
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus